WE ARE INTO SHARING

Regulatory Intelligence

Stay Up To Date

Latest regulatory changes

Price display of OTC medicines

Price display of OTC medicines

Europe Following a question from a member state, the European Court has ruled that certain forms of price indications can incite irrational use, which is not allowed in public advertising of OTC medicines. They decided that the following situations incite irrational...

read more
New fees for food supplement notifications

New fees for food supplement notifications

Belgium Due to the publication of the Royal decree about fees for raw materials and products (RD of 13 novembre 2011), the amount of the fees for notifications of food supplements has been modified. From May 21st 2023, the fee for a food supplement notification will...

read more
Revision IML Code of Ethics

Revision IML Code of Ethics

Luxembourg As previously announced, IML, the association of the innovative pharmaceutical industry in Luxembourg has revised and updated their Code of Ethics. The proposed amendments have been approved at the General Assembly held on 17 April 2023. The amounts of...

read more
New guideline on the use of D-mannose in food supplements

New guideline on the use of D-mannose in food supplements

Belgium The Mixed Committee of the FAMHP (which examines the 'grey zone' products) has issued a new guideline regarding the use of D-mannose in food supplements. Products with an amount of D-mannose higher than 750 mg/day can have a significant physiological effect....

read more
Adjusted fees for applications to EMA

Adjusted fees for applications to EMA

Europe Every year, the European Commission adopts a regulation adjusting the fees payable to the Agency with reference to the inflation rate in the European Union for the previous year. The 2022 inflation rate was 10.4%. The adjusted fees for all...

read more
MDR/IVDR Implementation – Amendment Transitional Provisions

MDR/IVDR Implementation – Amendment Transitional Provisions

Europe Due to lack of Notified Body (NB) capacity, lack of access to NB for SMEs, supply chain disruptions (Covid-19, Ukraine war,…),…the MDR implementation is creating bottlenecks in product certification. A new regulation ((EU) 2023/607) has been published, amending...

read more
Medical devices – turnover declaration

Medical devices – turnover declaration

Belgium As from the start of 2023, a new system for funding market surveillance of medical devices by FAMHP applies. Unlike before, this will no longer be limited to the sale of medical devices to retailers and end users.  All actors that carry out an activity...

read more
Update instructions for distribution of DHPC in Luxembourg

Update instructions for distribution of DHPC in Luxembourg

Luxembourg Division de la Pharmacie et des Médicaments de la Direction de la Santé has published updated instructions for the distribution of DHPC in Luxembourg (version 2.0 - 02/2023). A significant change in the updated version is the addition of the paragraph...

read more
Update Procedure for MA applications in Luxembourg

Update Procedure for MA applications in Luxembourg

Luxembourg On 20 January 2023, the Luxembourg authorities updated their document ‘Procedure for marketing authorisation applications in Luxembourg’, version 3.A new tab was created in the excel file with information regarding the Product information. The DPM of...

read more
Want To Join

Our Current Open Vacancies

Junior Consultant vacancy

Are you keen to discover the pharmaceutical industry and to get introduced to Quality Assurance, Pharmacovigilance, Regulatory Affairs and/or Promotion & Publicity for pharma and healthcare products? As Junior Consultant at IN2Pharma, you will be trained in several of these domains and depending on your skills and interest, we will find out together where your passion lies. Do you hold a Master degree in pharmaceutical or other sciences and are you eager to learn? Apply by sending your CV and motivation to jobs@in2Pharma.com

Download Vacancy

Medical Affair Vacancy

We are looking to expand our team with a Medical Affairs colleague who has the ambition and potential to grow in our organization. All projects within IN2Pharma are worked on in small teams of 2-5 people
and for some projects, you also work on site at the clients’ offices for (max.) 1 or 2 days per week.

Download Vacancy

QA Consultant

We are looking to expand our team with a Quality Assurance colleague who has the ambition and potential to grow in our organization. All projects within IN2Pharma are worked on in small teams of 2-5 people and for some projects, you also work on site at the clients’ offices for (max.) 1 or 2 days per week.

Download Vacancy

Stay Up To Date

In2Pharma News

Phone

+32 16 891 600

Location

Hof Ter Loonst
Terloonststraat 22
1910 Kampenhout
Belgium

Email

info@in2pharma.com

Social Media